Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
07/23/20192:21PMDow Jones NewsCorrection to article about drug makers using DNA dataNYSE:GSKGSK plc
07/23/20197:34AMDow Jones News23andMe, Glaxo Mine DNA Data in Hunt for New DrugsNYSE:GSKGSK plc
07/22/201912:52PMDow Jones NewsGlaxoSmithKline's ViiV Healthcare Finds Positive Data In HIV Drug StudyNYSE:GSKGSK plc
07/22/201912:38PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/19/20192:03PMEdgar (US Regulatory)Securities Registration (ads, Delayed) (f-6)NYSE:GSKGSK plc
07/15/20195:28PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/15/20195:08PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/15/20192:08PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/15/201910:30AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/15/20198:12AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/15/20192:43AMDow Jones NewsGlaxoSmithKline: Phase 3 Study of Zejula Met Trial ObjectivesNYSE:GSKGSK plc
07/12/20191:13PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/12/20191:04PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/11/20195:02AMDow Jones NewsEU Approves With Conditions GlaxoSmithKline's Acquisition of Pfizer's Consumer Health BusinessNYSE:GSKGSK plc
07/10/201912:00PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/10/20196:17AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/10/20192:54AMDow Jones NewsGlaxoSmithKline, Pfizer's HIV Treatment Meets Primary Endpoint in TrialNYSE:GSKGSK plc
07/08/20197:13AMDow Jones NewsFulcrum Therapeutics Sets IPO at 4.5 Million Shares; Sees Pricing at $16-$18 ApieceNYSE:GSKGSK plc
07/03/20197:59AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
07/02/20192:10PMDow Jones NewsSouth Africa Gives Conditional Go-Ahead to GSK-Pfizer JV -ReutersNYSE:GSKGSK plc
07/01/201910:46AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
06/26/20197:28PMDow Jones NewsLiquidia Technologies Gets Right to Develop More Products in Revised GlaxoSmithKline AgreementNYSE:GSKGSK plc
06/20/20196:53AMDow Jones NewsGSK Offers Concessions on Pfizer JV to Quell EU Antitrust FearsNYSE:GSKGSK plc
06/14/20198:04AMDow Jones NewsMorphic Holding Sets IPO at 5 Million Shares; Sees Pricing at $14-$16 ApieceNYSE:GSKGSK plc
06/12/20191:32PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
06/07/20196:38AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
06/06/20195:15PMBusiness WireNucala (mepolizumab) Gains FDA Approval for Two New Self-Administration OptionsNYSE:GSKGSK plc
06/04/20196:22AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
06/03/201911:12AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
05/31/20192:05PMEdgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK